CMS Waivers, Flexibilities, and the Transition Forward from the COVID-19 Public Health Emergency
The Centers for Medicare & Medicaid Services (CMS) recently released a fact with an overview of how flexibilities allows during the Federal Public Health Emergency may change as the PHE ends on May 11, 2023. Below are a few highlights; you can read the full fact sheet here
COVID-19 vaccines, testing, and treatments
Medicaid and CHIP
Vaccines, Testing, and Treatment: As a result of the American Rescue Plan Act of 2021 (ARPA),
states must provide Medicaid and CHIP coverage without cost sharing for COVID-19
vaccinations, testing, and treatments through the last day of the first calendar quarter that begins
one year after the last day of the COVID-19 PHE. If the COVID-19 PHE ends as expected on
May 11, 2023, this coverage requirement will end on September 30, 2024.
After that date, many Medicaid and CHIP enrollees will continue to have coverage for COVID19 vaccinations. After the ARPA coverage requirements expire, Medicaid and CHIP coverage of
COVID-19 treatments and testing may vary by state.
Additionally, 18 states and U.S. territories have opted to provide Medicaid coverage to uninsured
individuals for COVID-19 vaccinations, testing, and treatment. Under federal law, Medicaid
coverage of COVID-19 vaccinations, testing, and treatment for this group will end when the
PHE ends.
Private Health Insurance
Vaccines: Most forms of private health insurance must continue to cover COVID-19 vaccines
furnished by an in-network health care provider without cost sharing. People with private health
insurance may need to pay part of the cost if an out-of-network provider vaccinates them.
Testing: After the expected end of the PHE on May 11, 2023, mandatory coverage for over-the-counter and laboratory-based COVID-19 PCR and antigen tests will end, though coverage will
vary depending on the health plan. If private insurance chooses to cover these items or services,
there may be cost sharing, prior authorization, or other forms of medical management may be
required.
Treatments: The transition forward from the PHE will not change how treatments are covered,
and in cases where cost sharing and deductibles apply now, they will continue to apply.
Access to Telehealth Services
Medicaid, CHIP, and Telehealth
For Medicaid and CHIP, telehealth flexibilities are not tied to the end of the PHE and have been
offered by many state Medicaid programs long before the pandemic. Coverage will ultimately
vary by state. CMS encourages states to continue to cover Medicaid and CHIP services when
they are delivered via telehealth.
To assist states with the continuation, adoption, or expansion of telehealth coverage, CMS has
released the State Medicaid & CHIP Telehealth Toolkit and a supplement that identifies for
states the policy topics that should be addressed to facilitate widespread adoption of telehealth:
https://www.medicaid.gov/medicaid/benefits/downloads/medicaid-chip-telehealth-toolkitsupplement1.pdf.
Private Health Insurance and Telehealth
As is currently the case during the PHE, coverage for telehealth and other remote care services
will vary by private insurance plan after the end of the PHE. When covered, private insurance
may impose cost-sharing, prior authorization, or other forms of medical management on
telehealth and other remote care services.
For additional information on your insurer’s approach to telehealth, contact your insurer’s
customer service number located on the back of your insurance card.
Medicaid Continuous Enrollment Condition
The continuous enrollment condition for individuals enrolled in Medicaid is no longer linked to
the end of the PHE. Under the Families First Coronavirus Response Act, states claiming a
temporary 6.2 percentage point increase in the Federal Medical Assistance Percentage (FMAP)
have been unable to terminate enrollment for most individuals enrolled in Medicaid as of March
18, 2020, as a condition of receiving the temporary FMAP increase.
As part of the Consolidated Appropriations Act, 2023, the continuous enrollment condition will
end on March 31, 2023. The temporary FMAP increase will be gradually reduced and phased
down beginning April 1, 2023 (and will end on December 31, 2023). For more information, visit
Medicaid.gov/unwinding.
Comments